Why Think About Diet When You Can Just Pump Out the Extra!
While it may seem like a ridiculous joke at first, but a company named Aspire Bariatrics has come up with AspireAssist, a weight loss machine that fights obesity. How does it do it? By simply pumping out food from your stomach. In a clinical trial, patients using AspireAssist lost three times more weight than those who got only diet and exercise counseling. In the first year, the most effective patients had shed up to 100 pounds.
What is the procedure?
During a 15-minute outpatient procedure, the AspireAssist tube is inserted. Compared to extensive orthopedic surgeries, patients can usually return home within one to two hours, and many can quickly return to work. The operation is frequently done under “twilight anesthesia” (also known as conscious sedation or Monitored Anesthesia Care) rather than general anesthesia, as is the case with many dental operations. The technique is remarkably similar to how feeding tubes are placed on a regular basis. Feeding tubes have been utilized for those who can’t eat with their mouths for the past 35 years.
How does it work?
AspireAssist works by lowering the number of calories intake by the body while assisting you in making gradual, healthy lifestyle adjustments. Food is instantly transported to the stomach after eating, where it is temporarily stored before the digesting process begins. The stomach starts breaking down food within the first hour after eating it and then transfers it onto the intestines, where calories are absorbed. AspireAssist allows patients to eliminate roughly 30 per cent of the food from the stomach before the calories are absorbed into the body, resulting in weight loss.
A tiny tube will be inserted into your stomach to connect the inside of your stomach to an inconspicuous button on the exterior of your abdomen to begin therapy. By joining a small, handheld device to the button after each meal, you can empty, or “aspirate,” up to 30% of your meal into the toilet through this tube. The device is about the size of a smartphone and fits into a compact case when not in use.
The aspiration procedure takes 5 to 10 minutes and occurs 20 to 30 minutes after consuming the entire meal. The procedure is carried out in the privacy of the restroom, with the food being drained into the toilet. The body still gets the calories it needs to function because aspiration only removes a third of the food.
This treatment is combined with lifestyle counseling. This program combines one-on-one counselling and group support groups to encourage healthier eating choices, lower portion sizes, and increased physical activity. A physician also oversees and supervises the therapy to verify that you are losing weight in a healthy manner.
Although minimal, there are risks!
Abdominal discomfort or pain, irritation, hardening, or inflammation of the skin around the site where the tube is placed, leakage, bleeding, and/or infection around the site where the tube is placed, and device migration into the stomach wall are all risks associated with the abdominal opening for the port valve. All of them have the potential to demand the device’s removal. There’s a chance that a chronic fistula, an irregular route between the stomach and the abdominal wall, will develop after the device is removed.
Uncontrolled hypertension, diagnosed bulimia, diagnosed binge eating disorder, night eating syndrome, certain forms of previous abdominal surgery, pregnancy or lactation, inflammatory bowel disease, or stomach ulcers are all contraindications to taking AspireAssist. Patients with a history of significant lung or cardiovascular disease, coagulation issues, chronic stomach pain, or those at high risk of medical problems from an endoscopic operation should not use AspireAssist.
The procedure has achieved FDA approval. Its approval is based on a study that included 111 patients who used the AspireAssist and 60 patients who did not. When the two groups were compared, the people who used the AspireAssist lost 12.1 per cent of their body weight on average, compared to 3.6 per cent in the control group.